Truist Financial Corp acquired a new position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,255 shares of the company’s stock, valued at approximately $213,000.
Other large investors have also bought and sold shares of the company. Stonebridge Capital Advisors LLC acquired a new stake in shares of BlackRock Health Sciences Trust in the 3rd quarter valued at approximately $31,000. Farmers & Merchants Investments Inc. acquired a new stake in BlackRock Health Sciences Trust in the fourth quarter valued at approximately $40,000. HBK Sorce Advisory LLC grew its stake in shares of BlackRock Health Sciences Trust by 7.0% during the third quarter. HBK Sorce Advisory LLC now owns 5,876 shares of the company’s stock worth $230,000 after buying an additional 386 shares during the last quarter. Consolidated Portfolio Review Corp increased its holdings in shares of BlackRock Health Sciences Trust by 36.0% during the third quarter. Consolidated Portfolio Review Corp now owns 9,067 shares of the company’s stock worth $355,000 after buying an additional 2,400 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new position in shares of BlackRock Health Sciences Trust in the 4th quarter valued at $7,800,000.
BlackRock Health Sciences Trust Price Performance
NYSE BME opened at $40.40 on Wednesday. BlackRock Health Sciences Trust has a twelve month low of $35.53 and a twelve month high of $42.86. The business’s fifty day moving average is $40.04 and its 200 day moving average is $40.33.
BlackRock Health Sciences Trust Announces Dividend
The company also recently declared a monthly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a dividend of $0.213 per share. This represents a $2.56 annualized dividend and a dividend yield of 6.33%. The ex-dividend date of this dividend is Tuesday, May 14th.
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Recommended Stories
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
